Somaiah, N., Van Tine, B. A., Wahlquist, A. E., Milhem, M. M., Hill, E. G., Garrett‐Mayer, E., . . . Kraft, A. S. (2021). A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma. Cancer, 127(6), 894-904. https://doi.org/10.1002/cncr.33216
Chicago-Zitierstil (17. Ausg.)Somaiah, Neeta, et al. "A Randomized, Open‐label, Phase 2, Multicenter Trial of Gemcitabine with Pazopanib or Gemcitabine with Docetaxel in Patients with Advanced Soft‐tissue Sarcoma." Cancer 127, no. 6 (2021): 894-904. https://doi.org/10.1002/cncr.33216.
MLA-Zitierstil (9. Ausg.)Somaiah, Neeta, et al. "A Randomized, Open‐label, Phase 2, Multicenter Trial of Gemcitabine with Pazopanib or Gemcitabine with Docetaxel in Patients with Advanced Soft‐tissue Sarcoma." Cancer, vol. 127, no. 6, 2021, pp. 894-904, https://doi.org/10.1002/cncr.33216.